Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$7.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 49 most recent Form 4 transactions.
| $19.6K |
| -0.3% |
| Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,400 | $63.69 | $89.2K | -1.3% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 13,874 | $62.63 | $869K | -11.5% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 21,926 | $62.03 | $1.4M | -15.3% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 37,500 | $15.46 | $579.8K | +35.6% | Open the original filing on SEC.gov |
| May 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,076 | $43.95 | $91.2K | -1.9% | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,174 | $46.65 | $101.4K | -2.0% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,250 | — | — | +4.0% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20,000 | $45.00 | $900K | -16.0% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $17.96 | $359.2K | +19.0% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,559 | $42.53 | $66.3K | -1.5% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 5,226 | $41.62 | $217.5K | -4.7% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,215 | $41.93 | $302.5K | -6.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 37,500 | $41.07 | $1.5M | -23.9% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 7,500 | $15.46 | $116K | +5.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $17.96 | $359.2K | +15.5% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $19.08 | $190.8K | +8.4% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 14,000 | — | — | +13.3% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $30.00 | $300K | -8.7% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $15.46 | $154.6K | +9.5% | Open the original filing on SEC.gov |
| Mar 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $28.09 | $280.9K | -8.7% | Open the original filing on SEC.gov |
| Mar 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $19.08 | $190.8K | +9.5% | Open the original filing on SEC.gov |
| Feb 17 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,321 | $28.26 | $122.1K | -3.9% | Open the original filing on SEC.gov |
| Feb 17 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 5,679 | $27.50 | $156.2K | -4.9% | Open the original filing on SEC.gov |
| Feb 17 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $19.08 | $190.8K | +9.5% | Open the original filing on SEC.gov |
| Feb 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 509 | $32.74 | $16.7K | -0.5% | Open the original filing on SEC.gov |
| Feb 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,485 | $32.07 | $79.7K | -2.3% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL | 7,175 | $32.12 | $230.5K | -6.2% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 66,960 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT | 25,110 | — | — | +27.8% | Open the original filing on SEC.gov |
| Jan 20 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 20 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $27.34 | $273.4K | -10.0% | Open the original filing on SEC.gov |
| Jan 20 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $19.08 | $190.8K | +11.1% | Open the original filing on SEC.gov |
| Sep 22, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 22, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $25.00 | $250K | -10.0% | Open the original filing on SEC.gov |
| Sep 22, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $19.08 | $190.8K | +11.1% | Open the original filing on SEC.gov |
| May 5, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,920 | $21.05 | $103.6K | -5.2% | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,920 | — | — | — | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,920 | — | — | +5.5% | Open the original filing on SEC.gov |